🛡️ Public data only — no PHI permitted on this instance.
SC
SeekingChartis
Investment Committee Memorandum | FL | 257 beds | Grade C | EBITDA uplift $17.6M
Investment Committee Memorandum

ADVENTHEALTH FISH MEMORIAL

CCN 100072 | VOLUSIA, FL | 257 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ADVENTHEALTH FISH MEMORIAL is a 257-bed suburban community hospital in VOLUSIA, FL with $239.4M in net patient revenue and a 1.7% operating margin. The hospital serves a payer mix of 27.8% Medicare, 2.8% Medicaid, and 69.4% commercial.

Thesis: Undervalued. Our ML models identify $17.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 1.7% to 9.1% (+736bps).

Net Revenue HCRIS$239.4M
Current EBITDA COMPUTED$4.1M
Operating Margin COMPUTED1.7%
Occupancy HCRIS52.3%
Revenue / Bed COMPUTED$932K
Net-to-Gross HCRIS22.0%
Distress Probability ML47.3%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
108
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 1.7% places it below the state median. Among 108 size-comparable peers (128-514 beds), the median margin is 3.2%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (128-514), prioritizing same-state peers. 108 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ADVENTHEALTH FISH MEMORIAL (Target)FL257$239.4M1.7%
MOFFITT CANCER CENTERFL218$1.91B16.0%
MAYO CLINIC FLORIDAFL304$1.09B21.6%
MOUNT SINAI MEDICAL CENTER OF FL481$904.2M12.2%
TALLAHASSEE MEMORIAL HOSPITALFL483$871.6M-4.8%
SHANDS JACKSONVILLE MEDICAL CEFL481$861.4M-7.1%
NICKLAUS CHILDRENS HOSPITALFL259$769.3M5.5%
HCA FLORIDA OCALA HOSPITALFL509$761.7M27.6%
MEMORIAL HOSPITAL WESTFL486$741.4M5.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $17.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$5.0M+210bp18mo
Cost to Collect4.5%2.5%$4.8M+200bp12mo
Denial Rate Reduction12.0%6.5%$4.7M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.9M+122bp9mo
Clean Claim Rate88.0%96.0%$153K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$5.0M
Cost to Collect
$4.8M
Denial Rate Reduction
$4.7M
A/R Days Reduction
$2.9M
Clean Claim Rate
$153K
Total EBITDA Uplift$17.6M
Current EBITDA$4.1M
+ RCM Uplift+$17.6M
Pro Forma EBITDA$21.8M
Current Margin1.7%
Pro Forma Margin9.1%
WC Released (1x)$9.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$6.4M$203.6M31.89x99.9%
Base (11x exit)10.0x11.0x$6.4M$226.0M35.41x104.1%
Bull Case9.0x11.0x$5.7M$286.3M49.82x118.5%
Bull (12x exit)9.0x12.0x$5.7M$314.0M54.65x122.6%
Bear Case11.0x10.0x$7.0M$113.4M16.15x74.4%
Bear (11x exit)11.0x11.0x$7.0M$127.0M18.09x78.4%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 108 hospitals with 128-514 beds
  • Same-state prioritization (n=109)
  • Comp margins: P25=-5.3% / P50=3.2% / P75=17.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.

Full EBITDA BridgeML AnalysisHospital ProfileStatistical ProfileDeal Screener